USE OF CHITOOLIGOMER FORMULATIONS TO MODIFY ABNORMAL ACTIVITY OF CHITINASE LIKE PROTEINS

摘要

The present invention provides a use, a composition and a method for treatment of degenerative disorders or diseases in tissues or such as connective tissue, central nervous system, cardiovascular tissue or the immune system. The composition of the present invention comprises chito-oligomers for reduction of abnormally high expression of chitinase like proteins in patients suffering disorders or diseases associated with connective tissue, central nervous system, cardiovascular tissue or the immune system.